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A simple and efficient four-step sequence for the synthesis of fused polyether arrays has been developed.
Cyclic ethers are installed by sequential alkynyl ether formation, carbocupration, ring-closing metathesis and
hydroboration with acidic workup. Crucially, the alkene required for the subsequent ring formation by ring-
closing metathesis is present in the substrate but is masked in the form of a vinylic silane, which prevents
competitive metathesis of the side chain. Generation of the reactive alkene from the unreactive vinylic silane is
accomplished by hydroboration and subsequent acid-mediated Peterson elimination of the intermediate
hydroxysilane.
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Introduction
Fused polyether natural products are produced by
various marine dinoflagellates and are found in
organisms that feed on these algae.[1,2] Members of
this family of natural products include the
brevetoxins,[3,4] ciguatoxins,[5–8] gambieric acids,[9,10]
gymnocins,[11,12] tamulamides,[13] yessotoxin,[14]
adriatoxin,[15] gambierol,[16] gambierone,[17] brevenal[18]
and maitotoxin,[19] the largest non-polymeric natural
product known. Many marine polyethers (e.g., the
ciguatoxins) are potent neurotoxins that affect verte-
brates at very low concentrations, but some possess
little or no neurotoxic activity and are potential lead
compounds for the development of therapeutic
agents. For example, the gambieric acids exhibit
potent anti-fungal activity and brevenal has been
identified as a lead for the development of treatments
for cystic fibrosis.[20,21]
Marine polyethers are some of the most structurally
complex and challenging targets confronting contem-
porary organic synthesis. They contain arrays of trans-
fused cyclic ethers, ranging in ring size from six to
nine, in which the position of the ether alternates
along the backbone. Several of the natural products
(e.g., the ciguatoxins and brevetoxins) possess eight-
and nine-membered rings embedded within their
structures. However, the most common sub-units
found in the fused polyethers are six- and seven-
membered cyclic ethers, and in many of the natural
products (e.g., gymnocin-A and gambierol,[11,16] Fig-
ure 1) the polycyclic array is composed entirely or
almost entirely of fused rings of these sizes.
Marine polyethers are popular targets for total syn-
thesis because of their size, structural complexity and the
synthetic challenges they present. They are also of
interest because of their potent biological activities. Total
syntheses of the brevetoxins,[22–26] ciguatoxins,[27–33]
gambieric acids,[34,35] gymnocins,[36,37] gambierol[38–42]
and brevenal[43–45] have been accomplished, but synthe-
ses of the larger natural products (i. e., those that possess
more than eight rings) are generally extremely lengthy
and cannot provide sufficient quantities of the natural
products for full biological evaluation or extensive
analogue synthesis. Consequently, new strategies for the
rapid construction of fused polyethers are required to
reduce the step count significantly and improve both
synthetic convergence and efficiency.
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In previous work, we have devised several poten-
tially efficient approaches to the synthesis of fused
polyether systems.[46–48] Our work has focused on the
use of ring-closing metathesis (RCM) reactions of enol
ethers,[49,50] allylic ethers[51,52] and alkynyl ethers[53–55]
to prepare six- to nine-membered cyclic ether units of
the type found in marine fused polyether natural
products. We have used these reactions iteratively and
in a bidirectional manner to prepare significant
portions of the large polyether natural products
CTX3C[56] and gambieric acid A.[57,58]
During our work, we have found that RCM
reactions of acyclic enol ethers and functionalization
of the resulting cyclic enol ethers is a particularly
effective sequence for the synthesis of polyether sub-
units that contain six- and seven-membered rings. In
contemporaneous studies, Rainier and co-workers
have demonstrated the power of RCM reactions of
enol ethers[59–62] and have used this method to
synthesise and gambierol and brevenal,[42,45] and to
construct significant fragments of the larger natural
products yessotoxin and adriatoxin.[63]
In the approach developed by us previously, an
acyclic enol ether 3 is prepared by methylenation of
an ester 1 or by carbocupration of an alkynyl ether 2
(Scheme 1).[57] The acyclic enol ether 3 is subjected to
RCM to provide the cyclic ether 4 that is then
hydroborated to give the alcohol 5. To repeat the
sequence and thereby construct a further ring, a series
of reactions is required to introduce an alkene into the
R3 substituent because the presence of an unprotected
terminal alkene is incompatible with the preceding
RCM and hydroboration reactions. Because of the
additional functionalisation reactions required to gen-
erate an alkene at the R3 position, a relatively efficient
four-step sequence is rendered much less efficient.
The additional steps in each iteration would have a
deleterious impact on the overall step count when
constructing polyethers that contain 10 or more fused
rings.
To accomplish ring construction as efficiently as
possible, we sought to develop a synthetic sequence
in which the alkene required for the subsequent RCM
reaction would be present in a masked form and
would be revealed after hydroboration but without
requiring additional steps. In the proposed sequence
of reactions, an acyclic enol ether 6, which contains a
group (X) in the side chain that could be converted
into an alkene, would be subjected to RCM to produce
the cyclic enol ether 7 (Scheme 2). Instead of the cyclic
enol ether 7 being subjected to hydroboration to give
the alcohol 8 followed by a multistep sequence to
produce the terminal alkene 9, the group X would be
chosen so that hydroboration and alkene formation
would be accomplished concurrently to give the
hydroxyalkene 9 directly from the enol ether 7. The
Figure 1. Structures of gymnocin A and gambierol.
Scheme 1. Synthesis of fused cyclic ethers by sequential RCM
and hydroboration.
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alcohol 9 would be converted into the enol ether 11
either by esterification to give 10 and subsequent
methylenation, or by sequential alkynyl ether forma-
tion and carbocupration. Thus, ring construction
would be complete in just four steps and the
sequence (6!7!9!11) could be repeated.
The power of the proposed iterative ring construc-
tion procedure could be further amplified by its
application in a bidirectional manner. We have dem-
onstrated that bidirectional synthesis can be used to
prepare the G–I fragment of the gambieric acids
(Scheme 3).[57] In course of this work, carbocupration of
the bis-alkynyl ether 12 was performed to give the bis-
enol ether 13 and a subsequent double RCM reaction
mediated by the Grubbs second generation pre-
catalyst (14) delivered the tricyclic bis-enol ether 15.
Final double hydroboration and acetal formation
afforded the tetracyclic alcohol 16. Application of the
new synthetic procedure in an analogous bidirectional
manner would allow construction of fused polycyclic
ethers to be accomplished at the rate of just two steps
per ring.
Results and Discussion
As outlined in Scheme 2, the development of a four-
step sequence for the construction of six- and seven-
membered cyclic ethers requires a group (X) that can
function as a latent alkene in the side chain during
RCM and then be converted into a terminal alkene
upon hydroboration so that additional steps are
avoided. These requirements led us to select a vinylic
silane as a latent terminal alkene because bulky,
electron-rich 2-trialkylsilyl-1-alkenes would be rela-
tively unreactive in metathesis reactions but could
Scheme 2. General scheme for iterative fused cyclic ether
construction.
Scheme 3. Bidirectional synthesis of the G–I fragment of the
gambieric acids.
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undergo subsequent hydroboration.[64] The resulting
hydroxysilane would then undergo Peterson elimina-
tion to reveal the unfunctionalised terminal alkene
required for the next iteration of the reaction
sequence.
The proposed new annulation sequence was ex-
plored using tetrahydropyranols derived from com-
mercially available 3,4,6-tri-O-benzyl-D-glucal (17;
Scheme 4). Epoxidation of the enol ether 17 with
dimethyldioxirane (DMDO)[65,66] afforded the epoxide
18 with high diastereofacial selectivity and subsequent
reaction with allylmagnesium bromide afforded the
alcohol 19 in excellent yield. Reaction of the epoxide
18 with either 2-methyl-2-propen-1-ylmagnesium
bromide or 3-buten-1-ylmagnesium bromide afforded
the alcohols 20 and 21 in modest yield.[67,68]
The alcohol 19 was the first substrate to be
subjected to the four-step annulation sequence
(Scheme 5). Greene’s one-pot method was used to
convert the alcohol 19 into the alkynyl ether 22 in
excellent yield.[69] Carbometallation of the alkynyl
ether using organocopper reagents prepared from the
Grignard reagents 23 and 24 afforded the enol ethers
25 and 26 in high yield.1 The key RCM reactions were
then effected by treatment of the enol ethers 25 and
26 with the ruthenium complex 14 in benzene at
reflux. In both cases, very high yields of the cyclic enol
ethers 27 and 28 were obtained. The vinylic silane was
unreactive under the RCM conditions and so the silyl
substituent did provide a high level of protection to
the side-chain alkene, as anticipated.
The final step in the sequence involved hydro-
boration of both the enol ether and vinylic silane in
the RCM products 27 and 28 and then immediate
acid-mediated Peterson elimination. Hydroboration
was accomplished by treatment of each RCM product
(27 and 28) with excess thexylborane followed by
oxidation under mild conditions. Peterson elimination
was performed simply by dissolving the crude hydro-
boration products in trifluoroacetic acid as part of the
workup procedure.[71] In the case of the enol ether 27,
the hydroboration and Peterson elimination sequence
delivered the alcohol 29a in 45% yield. The enol ether
28 was found to be an even better substrate; in this
case, the alcohol 29a was obtained in 62% yield along
with the diastereomeric alcohol 29b in 11% yield after
sequential hydroboration and Peterson elimination.
The alcohol 29b was converted into the required
diastereomeric alcohol 29a by sequential oxidation,
base-mediated epimerization and ketone reduction.
Most polyether natural products possess at least
one methyl substituent at a ring junction position, and
so we wanted to discover whether the annulation
sequence could accommodate this structural feature
(Scheme 6). The alcohol 20 was converted into the
Scheme 4. Synthesis of the alcohols 19–21 from 3,4,6-tri-O-
benzyl-D-glucal (17).
Scheme 5. Four-step sequence for the synthesis of the bicyclic
ether 29a from the cyclic ether 19.
1The Grignard reagent 24 was prepared from the
corresponding bromide, see ref. [70].
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alkynyl ether 30 using the one-pot procedure that had
been employed to prepare alkynyl ether 22 from the
alcohol 19 (Scheme 5).[69] Carbometallation of the
alkynyl ether 30 using an organocopper reagent
prepared from the Grignard reagent 24 was performed
to give the enol ether 31.[70] The RCM reaction of the
acyclic enol ether 31 to give the tetrasubstituted cyclic
enol ether was challenging and a complex mixture of
products was obtained from the reaction mediated by
the complex 14. The mixture was then subjected to
immediate hydroboration using thexylborane and the
resulting crude hydroxysilane was dissolved in tri-
fluoroacetic acid to facilitate Peterson elimination. The
required alcohol 32 was obtained in modest yield after
sequential RCM, hydroboration and Peterson elimina-
tion.
In the annulation sequences shown in Schemes 5
and 6, a butenyl side chain had been installed, which
would be used to construct a seven-membered cyclic
ether in a further iteration of the four-step reaction
sequence. However, in many cases a propenyl side
chain would be required to construct a six-membered
ring in the subsequent RCM reaction. The enol ether
33, prepared from the alkynyl ether 22 by the route
shown in Scheme 7, was used to test the reaction
sequence. The organocopper reagent used in the
carbocupration reaction was prepared by the addition
of a higher-order cuprate, generated by the reaction
of phenyldimethylsilyl lithium with copper(I) cyanide,
to allene.[72] Reaction of the alkynyl ether 22 with an
excess of the organocopper reagent delivered the enol
ether 33 in 73% yield. Subsequent ring formation by
RCM was successful and the bicyclic enol ether 34 was
produced in good yield. However, this compound
proved to be unstable and so the hydroboration, and
Peterson elimination sequence was not explored.
We had shown that the four-step sequence could
be used to construct fully-functionalised six-mem-
bered cyclic ethers and we wanted to establish
whether the sequence could be used to construct a
seven-membered cyclic ether. The requisite RCM
precursor – enol ether 37 – was prepared from the
alcohol 21 by conversion into the alkynyl ether 36 and
subsequent carbocupration of the alkyne with an
organocopper reagent generated from the Grignard
reagent 24 (Scheme 8).
Scheme 6. Four-step sequence for synthesis of the bicyclic ether 32 from the cyclic ether 20.
Scheme 7. Synthesis of a fused bicyclic ether with a propenyl
side chain.
Scheme 8. Synthesis of cyclisation precursor 37.
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The RCM reaction of the enol ether 37 proved to
be more challenging than the RCM reactions of
substrates 25, 26, 31 or 33. The RCM reaction was very
slow and isomerisation of the substrate 37 to give the
alkene 38 occurred in competition with the cyclisation
reaction to give the required seven-membered cyclic
enol ether 39.2 The RCM reaction of the isomerised
alkene produced the previously characterized cyclic
enol ether 28, the lower homologue of the required
product 39. Thus, a mixture of the cyclic enol ethers
28 and 39 was obtained, but separation was not
possible because the compounds were prone to
hydrolysis on extended contact with silica gel. The
mixture of enol ethers was subjected to immediate
hydroboration and acidic workup to produce the
required alcohol 40 and the previously prepared
alcohol 29a (Scheme 9). However, neither the alcohol
40 nor homologous compound 29a could be isolated
from the complex mixture of products and attempts
to suppress isomerization of the terminal alkene 37 to
give 1,2-disubstituted alkene 38 by the inclusion of
various additives were unsuccessful.3[73]
Although it was not possible to suppress isomer-
ization of 37, the fact that this reaction occurs might
offer some advantages, provided the process can be
controlled fully. In principle, the ability to perform
isomerization or suppress it completely would allow
either 29a or 40 to be prepared from the same
substrate (37) and would obviate the need to perform
the sequence shown in Scheme 7, which involves a
sensitive intermediate and proved difficult to com-
plete. Work is continuing to discover whether it is
possible to accomplish complete in situ isomerization
of 37 to give 38 prior to RCM when a six-membered
cyclic ether is required and suppress the reaction
when the construction of a seven-membered ring is
required.
Conclusions
A four-step sequence of alkynyl ether formation,
carbocupration, ring-closing metathesis and hydro-
boration with acidic workup, has been used to
synthesise fused polyether systems. The alkene re-
quired for the further ring construction by a subse-
quent RCM reaction is present in the substrate but is
protected in the form of a vinylic silane, which
prevents competitive side-chain metathesis. The four-
step sequence can be used to add tetrahydropyranol
rings to existing polyether arrays and ring junction
methyl groups are tolerated. The use of the reaction
for the synthesis of seven-membered cyclic ethers is
hampered by competitive isomerization of the termi-
nal alkene in the substrate prior to RCM, which leads
to a mixture of the required seven-membered cyclic
enol ether and the corresponding six-membered cyclic
enol ether.
2Competitive isomerization of terminal alkenes during
RCM reactions of dienes to form medium-sized rings is
well precedented. For examples, see ref. [73].
Scheme 9. Synthesis of a bicyclic ether containing an oxepane.
3The following reagents were added to the ring-closing
metathesis reaction in unsuccessful attempts to suppress
isomerization: triethylamine, water, styrene, tricyclohex-
ylphosphine and tricyclohexylphosphine oxide.
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Experimental Section
Materials and Instrumentation
1H-NMR spectra were recorded on Bruker DRX 500, AM
400 and AV 400 instruments at ambient temperature.
All spectra were obtained from samples dissolved in
deuterochloroform unless otherwise stated. Chloro-
form or tetramethylsilane was used as the internal
reference (δ 7.27 and 0.0 ppm, resp.). J values are
given in Hertz. Signals in NMR spectra are described as
singlets (s), doublets (d), triplets (t), quartets (q),
multiplets (m), broad (b) or a combination of these,
which refers to the spin–spin coupling pattern
observed. 13C-NMR spectra were recorded on either
Bruker DRX 500 (125 MHz) or AV 400 (100 MHz) instru-
ments at ambient temperature. All spectra were
obtained from samples dissolved in deuterochloroform
unless otherwise stated, using chloroform as the
internal reference (δ 77.1 ppm). IR spectra were
recorded in the range 4000–600 cm  1 on a Perkin-
Elmer 1600 series FT-IR spectrometer. Melting points
were determined using a Mel-Temp II melting point
apparatus. Elemental analyses were carried out on an
Exeter analytical Inc. CE-440 Elemental analyser. Mass
spectra and accurate mass measurements were re-
corded under EI, FAB, CI and ES conditions on a
FISSONS VG Autospec instrument. Optical rotations
were determined using a Jasco DIP-370 digital polar-
imeter.
Synthetic Procedures and Compound Characterisation
(1S,3R,4R,5S,6R)-4,5-Bis(benzyloxy)-3-[(benzyloxy)-
methyl]-2,7-dioxabicyclo[4.1.0]heptane (18). To a
solution of 3,4,6-tri-O-benzyl-D-glucal (= (2R,3S,4R)-3,4-
bis(benzyloxy)-2-[(benzyloxy)methyl]-3,4-dihydro-2H-
pyran; 17; 5.0 g, 12 mmol) in dichloromethane (20 mL)
at 0 °C was added dropwise a solution of freshly
prepared dimethyldioxirane (300 mL of a 0.08 M
solution in acetone, 24 mmol).[65,66] After the addition,
the solvent was removed in vacuo (<5 °C). The
resulting solid was dissolved in dichloromethane and
dried (Na2SO4). The solvent was removed in vacuo
(<5 °C) to give the epoxide 18 as a white solid (5.2 g,
quant.). M.p.=62–64 °C (Lit.[74] 77–78 °C). [α]D17= +
13.7 (c=0.42 in CHCl3) (Lit.
[74] [α]D
25= +31.1 (c=0.5 in
CHCl3)).
1H-NMR (500 MHz, CDCl3): 7.42–7.20 (15 H, m);
4.98 (1 H, d, J=11.4); 4.85 (1 H, br. s); 4.79 (1 H, d, J=
11.4); 4.54 (1 H, d, J=11.9); 7.53 (1 H, d, J=11.8); 4.44
(1 H, d, J=11.9); 4.43 (1 H, d, J=11.8); 4.09 (1 H, d, J=
7.8); 4.00 (1 H, bd, J=10.1); 3.92 (1 H, ddd, J=10.1, 7.7,
1.7); 3.85 (1 H, dd, J=10.8, 3.1); 3.68 (1 H, dd, J=10.8,
1.3); 2.81 (1 H, t, J=2.4). 13C-NMR (125 MHz, CDCl3):
139.1; 138.7; 138.2; 128.4; 128.3; 128.2; 128.1; 128.0;
127.8; 127.6; 127.4; 127.4; 79.4; 77.5; 74.6; 74.3; 73.3;
71.7; 69.9; 68.5; 52.2. HR-CI–MS (NH3): 432.1911 (M
+,
C27H28O5




crude epoxide 18 (5.2 g, 12 mmol) was dissolved in
dry THF (120 mL) and the solution was cooled to
  20 °C. Allylmagnesium chloride (12 mL of a 2.0 M
solution in THF, 24 mmol) was added dropwise and
the mixture was stirred for 2 h. The reaction was
quenched by the addition of a saturated solution of
NH4Cl (50 mL) and the resulting mixture was extracted
with dichloromethane (3×100 mL). The combined
organic extracts were dried (MgSO4) and the solvent
was removed in vacuo. The residue was purified by
flash column chromatography over silica gel (Et2O/
hexane 1 :1) to give the alcohol 19 (4.95 g, 92%) as a
white solid. Rf=0.52 (Et2O/hexane 1 :1). M.p.=66–
67 °C (Lit.[75] 63–65 °C). [α]D20= +40.8 (c=1.28 in
CHCl3) (Lit.
[75] [α]D= +37.5 (c=0.9 in CHCl3)). IR
(CHCl3): 3610, 2956, 1460, 1047.
1H-NMR (500 MHz,
CDCl3): 7.49–7.31 (15 H, m); 6.06 (1 H, dddd, J=17.1,
10.1, 7.0, 7.0); 5.26 (1 H, dd, J=17.1, 1.9); 5.20 (1 H, d,
J=10.1); 5.08 (1 H, d, J=11.5); 4.93 (1 H, d, J=10.9);
4.87 (1 H, d, J=11.5); 4.76 (1 H, d, J=12.3); 4.73 (1 H, d,
J=10.9); 4.70 (1 H, d, J=12.3); 3.88–3.80 (2 H, m); 3.72
(1 H, t, J=9.3); 3.60 (1 H, t, J=8.9); 3.57–3.53 (1 H, m);
3.49 (1 H, t, J=8.9); 3.39 (1 H, ddd, J=8.9, 7.5, 3.3);
2.73–2.67 (1 H, m); 2.44 (1 H, dt, J=14.6, 7.2); 2.27 (1
H, br. s). 13C-NMR (125 MHz, CDCl3): 138.6; 138.3; 138.1;
134.7; 128.7; 128.5; 128.4; 128.0; 127.9; 127.8; 127.6;
117.1; 86.8; 79.2; 78.8; 78.5; 75.2; 74.8; 73.5; 68.9; 36.2.
HR-EI-MS: 474.2416 (M+, C30H34O5
+; calc. 474.2406). EI-
MS: 474 (1, M+), 383 (45), 293 (1), 259 (2), 181 (11), 133
(9), 91 (100). Anal. calc. for C30H34O5: C 75.92, H 7.22;
found: C 76.15, H 7.28.
(2S,3S,4R,5R,6R)-4,5-Bis(benzyloxy)-6-[(benzyl-
oxy)methyl]-2-(2-methylprop-2-en-1-yl)oxan-3-ol
(20). Crude epoxide 18 (5.0 g, 12 mmol) was dissolved
in dry THF (100 mL) and the solution was cooled to
  20 °C. 2-Methylallylmagnesium chloride (46 mL of
0.50 M solution in THF, 23 mmol) was added dropwise
and the mixture was stirred for 2 h. The reaction was
quenched by the addition of a saturated solution of
NH4Cl (100 mL) and the resulting mixture was ex-
tracted with dichloromethane (3×80 mL). The com-
bined organic extracts were dried (MgSO4) and the
Helv. Chim. Acta 2019, 102, e1900161
www.helv.wiley.com (7 of 15) e1900161 © 2019 The Authors. Helvetica Chimica Acta Published by Wiley-VHCA AG
solvent removed in vacuo. The resulting residue was
purified by flash column chromatography over silica
gel (Et2O/hexane 1 :2) to give alcohol 20 (2.9 g, 52%)
as a white solid. Rf=0.67 (Et2O/hexane 1 :1). M.p.=
69–70 °C. [α]D20= +30.4 (c=1.15 in CHCl3). IR (CHCl3):
3600, 2869, 1602, 1454, 1360, 1075, 992, 895. 1H-NMR
(400 MHz, CDCl3): 7.41–7.23 (15 H, m); 4.99 (1 H, d, J=
11.5), 4.87(2 H, br. s), 4.85 (1 H, d, J=10.8), 4.80 (1 H, d,
J=11.5), 4.67 (1 H, d, J=12.3), 4.65 (1 H, d, J=10.8),
4.61 (1 H, d, J=12.3), 3.78 (1 H, dd, J=11.0, 2.0), 3.72
(1 H, dd, J=11.0, 4.3), 3.65 (1 H, dd, J=9.6, 9.0), 3.57–
3.51 (1 H, m); 3.46 (1 H, ddd, J=9.6, 4.3, 2.0), 3.41–3.28
(2 H, m); 2.58 (1 H, dd, J=15.0, 2.3), 2.20 (1 H, dd, J=
15.0, 7.6), 2.19 (1 H, d, J=0.9), 1.84 (3 H, s). 13C-NMR
(100 MHz, CDCl3): 143.2; 138.7; 138.4; 138.2; 128.7;
128.5; 128.4 (CH); 128.0 (CH); 127.9; 127.9; 127.8; 127.6;
112.6; 86.9; 79.2; 78.5; 78.2; 75.3; 74.8; 74.3; 73.5; 69.1;
40.3; 23.3. HR-EI-MS: 488.2538 (M+, C31H36O5
+; calc.
488.2563). EI-MS: 488 (1, M+), 397 (60), 235 (14), 181
(35), 91 (100), 51 (16).
(2S,3S,4R,5R,6R)-4,5-Bis(benzyloxy)-6-[(benzyl-
oxy)methyl]-2-(but-3-en-1-yl)oxan-3-ol (21). Crude
epoxide 18 (6.4 g, 15 mmol) was dissolved in dry THF
(150 mL) and the solution was cooled to   20 °C. 3-
Butenylmagnesium bromide (30 mL of a 0.50 M solu-
tion in THF, 60 mmol) was added dropwise and the
mixture was stirred for 3 h. The reaction was quenched
by the addition of a saturated solution of NH4Cl
(100 mL), and the resulting mixture was extracted with
dichloromethane (3×150 mL). The organic extracts
were combined and dried (MgSO4) and the solvent
was removed in vacuo. The resulting residue was
purified by flash column chromatography over silica
gel (1 :1 Et2O/hexane) to give the alcohol 21 (2.1 g,
33%) as a white solid. Rf=0.62 (Et2O/hexane 1 :1).
M.p.=60–62 °C. [α]D23= +24.8 (c=1.01 in CHCl3). IR
(CHCl3): 3516, 2868, 1640, 1603, 1454, 1076, 996, 912.
1H-NMR (400 MHz, CDCl3): 7.29–7.14 (15 H, m); 5.75 (1
H, dddd, J=17.0, 10.2, 6.7, 6.7); 4.96 (1 H, dddd, J=
17.0, 1.7, 1.7, 1.7); 4.88 (1 H, dddd, J=10.2, 1.7, 1.3, 1.3);
4.60 (1 H, d, J=11.7); 4.55 (1 H, d, J=11.4); 4.51 (1 H, d,
J=11.7); 4.50 (1 H, d, J=12.1); 4.49 (1 H, d, J=11.4);
4.44 (1 H, d, J=12.1); 3.92 (1 H, ddd, J=5.5, 5.1, 4.4);
3.81 (1 H, dt, J=9.6, 3.9); 3.72 (1 H, dd, J=10.2, 5.7);
3.66 (1 H, t, J=5.7); 3.63 (1 H, dd, J=10.2, 5.1); 3.60–
3.53 (2 H, m); 2.74 (1 H, d, J=7.9); 2.19–2.08 (1 H, m);
2.07–1.96 (1 H, m); 1.71 (1 H, dddd, J=14.2, 9.3, 9.3,
5.5); 1.58 (1 H, dddd, J=14.2, 9.6, 6.8, 4.4). 13C-NMR
(125 MHz, CDCl3): 142.1; 141.9; 141.8; 141.3; 132.3;
132.3; 132.2; 131.7; 131.5; 132.4; 131.4; 118.6; 82.1;
81.2; 80.9; 80.7; 79.1; 76.8; 75.1; 73.6; 72.1; 33.4; 31.0.
HR-FAB-MS: 489.2667 ([M+H]+, C31H37O5
+; calc.
489.2641). FAB-MS: 489 (9, [M+H]+), 307 (21), 289
(11), 154 (93), 136 (68), 91 (100). Anal. calc. for
C31H36O5: C 76.20, H 7.43; found: C 75.98, H 7.28.
(2R,3R,4S,5S,6S)-3,4-Bis(benzyloxy)-2-[(benzyl-
oxy)methyl]-5-(ethynyloxy)-6-(prop-2-en-1-yl)ox-
ane (22). A solution of alcohol 19 (1.0 g, 2.1 mmol) in
Et2O (10 mL) was added slowly by cannula to a
suspension of KH (200 mg, 4.99 mmol) in Et2O (20 mL)
at room temperature. The mixture was stirred for
10 min and then cooled to 0 °C. Freshly distilled
trichloroethene (320 mg, 2.44 mmol) in Et2O (2 mL)
was added dropwise to the solution. The mixture was
allowed to warm to room temperature and stirred for
1 h. The solution was cooled to   78 °C, and BuLi
(2.5 mL of a 2.5 M solution in hexanes, 6.3 mmol) was
added dropwise. The mixture was stirred at   78 °C for
30 min, then allowed to warm to   40 °C and stirred at
that temperature for 45 min. The reaction was
quenched by the addition of methanol (5 mL) and the
mixture was poured into a saturated solution of NH4Cl
(50 mL). The mixture was extracted with Et2O (50 mL)
and the organic extract was washed with brine
(50 mL) and then dried (MgSO4). The solvent removed
in vacuo and the residue was purified by flash column
chromatography over silica gel (Et2O/hexane 1 :9 with
1% Et3N) to give alkyne 22 (960 mg, 91%) as a
colourless oil. Rf 0.45 (Et2O/hexane 1 :9). [α]D
20= +24.9
(c=0.950 in CHCl3). IR (CHCl3) 3322, 2869, 2154, 1642,
1454, 1095, 996, 913. 1H-NMR (500 MHz, CDCl3): 7.40 (2
H, dd, J=7.3, 1.2); 7.35–7.23 (6 H, m); 7.18–7.15 (2 H,
m); 5.91 (1 H, dddd, J=17.4, 10.5, 7.1, 7.1); 5.21 (1 H,
dd, J=17.4, 1.3); 5.13 (1 H, d, J=10.5); 4.96 (1 H, d, J=
10.6); 4.81 (1 H, d, J=10.8); 4.79 (1 H, d, J=10.8); 4.59
(1 H, d, J=12.2); 4.55 (1 H, d, J=10.6); 4.53 (1 H, d, J=
12.2); 3.90 (1 H, dd, J=9.0, 8.8); 3.85 (1 H, dd, J=9.6,
9.0); 3.71 (1 H, dd, J=11.2, 2.0); 3.65 (1 H, dd, J=11.2,
4.4); 3.61 (1 H, dd, J=9.8, 8.8); 3.53 (1 H, ddd, J=9.6,
7.1, 3.2); 3.41 (1 H, ddd, J=9.8, 4.4, 2.0); 2.68–2.63 (1 H,
m); 2.40 (1 H, dt, J=14.5, 7.1); 1.63 (1 H, s). 13C-NMR
(125 MHz, CDCl3): 138.2; 138.0; 133.3; 128.5; 128.4;
128.3; 128.0; 127.9; 127.8; 127.7; 118.3; 89.0; 88.0; 83.2;
79.0; 78.1; 76.4; 75.4; 75.2; 73.5; 68.7; 35.6; 28.3. HR-CI–






(27). A mixture of copper bromide (213 mg,
1.50 mmol) and lithium bromide (140 mg, 1.50 mmol)
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was dried at 60 °C for 4 h under high vacuum
(<1 mbar) and then suspended in THF (10 mL). The
suspension was cooled to   90 °C and the Grignard
reagent 23 (3.0 mL of a 0.50 M solution in THF,
1.5 mmol) was added dropwise over a period of 5 min.
The resulting solution was stirred at   90 °C for 5 min.
A solution of the alkynyl ether 22 (500 mg, 1.00 mmol)
in THF (10 mL) was added dropwise over 5 min at
  90 °C and the mixture was warmed to   78 °C then
stirred for a further 30 min. The reaction was
quenched by the addition of a 10% aqueous solution
of NH4OH (50 mL) and the mixture was extracted with
Et2O (2×50 mL). The combined organic extracts were
dried (MgSO4) and the solvent was removed in vacuo.
The residue was purified by flash column chromatog-
raphy over silica gel (hexane!Et2O/hexane 20 :1 with
1% Et3N) to afford enol ether 25 (530 mg, 84%) as a
colourless oil. Rf 0.45 (Et2O/hexane 1 :9). The unstable
enol ether was used immediately in the subsequent
RCM reaction.
A solution of alkene 25 (530 mg, 0.84 mmol) in
toluene (50 mL) was added to a solution of ruthenium
complex 14 (40 mg, 46 μmol) in toluene (50 mL) at
room temperature under an atmosphere of argon. The
solution was heated to 80 °C and stirred at this
temperature for 4 h. The solvent was removed in vacuo
and the crude product was purified by flash column
chromatography over silica gel (Et2O/hexane 1 :20!
1 :10 with 1% Et3N) to give cyclic enol ether 27
(432 mg, 86%) as colourless oil. Rf=0.42 (Et2O/hexane
1 :9). [α]D
20= +39.0 (c=1.05 in CHCl3). IR (CHCl3):
2913, 2862, 1678, 994, 862, 839. 1H-NMR (500 MHz,
CDCl3): 7.61–7.58 (2 H, m); 7.54–7.40 (11 H, m); 7.37–
7.33 (2 H, m); 5.79–5.76 (1 H, m); 5.54 (1 H, d, J=2.7);
5.24 (1 H, d, J=11.2); 5.07 (1 H, d, J=10.8); 5.00 (1 H, d,
J=11.2); 4.79 (1 H, d, J=12.3); 4.72 (1 H, d, J=12.3);
4.71 (1 H, d, J=10.8); 4.66 (1 H, dd, J=3.5, 1.9); 3.98–
3.78 (5 H, m); 3.74 (1 H, ddd, J=9.7, 4.5, 1.9); 3.68–3.62
(1 H, m); 2.60–2.48 (3 H, m); 2.43–2.31 (3 H, m); 0.28 (9
H, s). 13C-NMR (125 MHz, CDCl3): 153.6; 151.4; 138.9;
138.4; 138.2; 128.5; 128.2; 128.1; 128.1; 127.8; 127.8;
124.4; 93.5; 84.5; 79.6; 79.1; 77.6; 75.3; 75.2; 73.6; 72.5;




silane (28). A mixture of copper bromide (520 mg,
3.60 mmol) and lithium bromide (320 mg, 3.60 mmol)
was dried at 60 °C for 4 h under high vacuum
(<1 mbar) and then suspended in THF (20 mL). The
suspension was cooled to   90 °C and the Grignard
reagent 24 (7.2 mL of a 0.5 M solution in THF,
3.6 mmol) was added dropwise over a period of 5 min.
The resulting mixture was stirred at   90 °C for 5 min.
A solution of the alkynyl ether 22 (1.5 g, 3.0 mmol) in
THF (20 mL) was added dropwise over 5 min at
  90 °C, and the mixture was allowed to warm to
  78 °C then stirred for a further 30 min. The reaction
was quenched by the addition of a 10% aqueous
solution of NH4OH (50 mL) and the mixture was
extracted with Et2O (2×120 mL). The combined organ-
ic extracts were dried (MgSO4) and the solvent
removed in vacuo. The residue was purified by flash
column chromatography over silica gel (hexane!
Et2O/hexane 1 :20 with 1% Et3N) to afford enol ether
26 (1.81 g, 86%) as a colourless oil. Rf 0.49 (Et2O/
hexane 1 :9). The unstable enol ether was used
immediately in the subsequent RCM reaction.
A solution of alkene 26 (1.8 g, 2.6 mmol) in toluene
(130 mL) was added to a solution of ruthenium
catalyst 14 (110 mg, 130 μmol) in toluene (130 mL) at
room temperature under an atmosphere of argon. The
solution was heated to 80 °C and stirred at this
temperature for 4 h. The solvent was removed in vacuo
and the crude product was purified by flash column
chromatography over silica gel (Et2O/hexane 1 :7 with
1% Et3N) to give cyclic enol ether 28 (1.6 g, 91%) as
colourless oil. Rf=0.45 (Et2O/hexane 1 :1). [α]D
20=
þ44:7 (c=1.01 in CHCl3). IR (CHCl3): 2912, 2863, 1678,
1454, 1028, 998, 910, 834. 1H-NMR (500 MHz, CDCl3):
7.79–7.74 (2 H, m); 7.66–7.62 (2 H, m); 7.61–7.48 (14
H, m); 7.44–7.40 (2 H, m); 6.00 (1 H, d, J=1.0); 5.73 (1
H, s); 5.26 (1 H, d, J=11.3); 5.15 (1 H, d, J=10.8); 5.04
(1 H, d, J=11.3); 4.86 (1 H, d, J=12.3); 4.79 (1 H, d, J=
12.3); 4.79 (1 H, d, J=10.8); 4.62 (1 H, d, J=4.5); 4.03–
3.93 (2 H, m); 3.95 (1 H, dd, 10.8, 4.5); 3.90 (1 H, t, J=
9.3); 3.86 (1 H, t, J=9.3); 3.82–3.76 (1 H, m); 3.68 (1 H,
ddd, J=9.5, 9.5, 6.3); 2.65–2.60 (2 H, m); 2.57 (1 H, dt,
J=16.0, 5.9) 2.43–2.32 (3 H, m); 0.65 (6 H, s). 13C-NMR
(125 MHz, CDCl3): 153.1; 149.2; 138.7; 138.2; 138.0;
133.8; 128.9; 128.2; 127.9; 127.8; 127.8; 127.7; 127.5;
127.5; 126.3; 93.3; 84.1; 79.2; 78.8; 77.4; 75.0; 74.9; 73.4;
72.1; 69.0; 33.2; 33.0; 27.2;   3.0.
(2S,4aS,6R,7R,8S,8aS)-7,8-Bis(benzyloxy)-6-
[(benzyloxy)methyl]-2-(but-3-en-1-yl)octahydropy-
rano[3,2-b]pyran-2-ol (29a) and (2R,4aS,6R,7R,8S,
8aS)-7,8-Bis(benzyloxy)-6-[(benzyloxy)methyl]-2-
(but-3-en-1-yl)octahydropyrano[3,2-b]pyran-2-ol
(29b). A solution of thexylborane (30 mL of a 0.50 M
solution in THF, 15 mmol) was added dropwise to the
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enol ether 28 (1.6 g, 2.4 mmol) in THF (50 mL) at
  20 °C. The mixture was stirred at   20 °C for 30 min
and then warmed to 0 °C. After a further 30 min, the
ice bath was removed, and the mixture stirred for 1 h.
The reaction was quenched by the slow addition of
methanol (5 mL). After 5 min, pH 7 buffer (20 mL) and
NaBO3 (1.64 g, 20 mmol) were added, and the mixture
was agitated vigorously for 3 h. AcOEt (100 mL) was
added, and the solution was washed with brine (2×
50 mL). The aqueous washings were extracted with
AcOEt (2×100 mL), and the combined organic extracts
were dried (MgSO4) and the solvent was removed in
vacuo. The residue was dissolved in AcOEt (200 mL)
and filtered through a plug of silica. The solvent was
removed in vacuo and the residue was dissolved in
neat trifluoroacetic acid (5 mL) and stirred for 2 min.
The acid was neutralised by slow addition of a
saturated aqueous solution of K2CO3 and the aqueous
mixture was extracted with Et2O (3 × 100 mL). The
combined organic extracts were dried (MgSO4), and
the solvent was removed in vacuo. The residue was
purified by flash column chromatography over silica
gel (Et2O/hexane 1 :4!4 :6) to give the alcohol 29a
(805 mg, 62%) as a white solid. Further elution gave
the alcohol 29b (145 mg, 11%) as a white solid.
Data for 29a. Rf=0.28 (Et2O/hexane 1 :1). M.p.=
80–81 °C. [α]D17=   7.3 (c=1.01 in CHCl3). IR (CHCl3):
3617, 3869,1640, 1604, 1454, 996, 913. 1H-NMR
(500 MHz, CDCl3): 7.51–7.47 (2 H, m); 7.46–7.46 (11 H,
m); 7.26–7.23 (2 H, m); 5.97 (1 H, ddd, J=16.9, 10.2,
6.6); 5.18–5.13 (1 H, m); 5.13 (1 H, d, J=10.9); 5.09 (1
H, d, J=10.2); 4.97 (1 H, d, J=10.7); 4.88 (1 H, d, J=
10.9); 4.71 (1 H, d, J=12.2); 4.64 (1 H, d, J=12.2); 4.60
(1 H, d, J=10.7); 3.82 (1 H, dd, J=10.7, 1.7); 3.76 (1 H,
dd, J=10.7, 4.9); 3.74 (1 H, dd, J=8.8, 8.4); 3.67 (1 H,
dd, J=9.2, 8.8); 3.60 (1 H, ddd, J=9.4, 4.9, 1.7); 3.48 (1
H, ddd, J=10.7, 9.5, 4.7); 3.28 (1 H, dd, J=9.4, 9.2);
3.26–3.21 (2 H, m); 2.56 (1 H, ddd, J=11.8, 4.3, 4.3);
2.51–2.42 (1 H, m); 2.35–2.25 (1 H, m); 2.08 (1 H, dddd,
J=16.3, 7.4, 7.0, 2.2); 1.85 (1 H, br. s); 1.70–1.58 (2 H,
m). 13C-NMR (125 MHz, CDCl3): 138.8; 138.3; 138.2;
138.0; 128.4; 128.1; 128.0; 127.9; 127.8; 127.7; 127.7;
115.0; 84.1; 82.2; 81.2; 79.2; 77.6; 75.3; 75.1; 73.9; 73.5;
69.7; 69.2; 38.8; 31.1; 29.8. HR-EI-MS: 544.2833 (M+,
C34H40O6
+; calc. 544.2825). EI-MS: 544 (1, M+), 454 (42),
363 (6), 209 (19), 181 (26), 91 (100) 65 (18). Anal. calc.
for C34H40O6: C 74.97, H 7.40; found C 75.16, H 7.35.
Data for 29b. Rf=0.18 (Et2O/hexane 1 :1). M.p.=
92–93 °C. [α]D23= +15.3 (c=0.63 in CHCl3). IR (CHCl3):
3612, 2926, 2869, 1640, 1454, 1364, 1088, 996, 913. 1H-
NMR (500 MHz, CDCl3): 7.40–7.20 (13 H, m); 7.13–7.08
(2 H, m); 5.85 (1 H, dddd, J=16.9, 10.2, 6.6, 6.6); 5.06 (1
H, dq, J=16.9, 1.6); 5.05 (1 H, d, J=11.0); 5.01 (1 H, ddt,
J=10.2, 1.6, 1.1); 4.85 (1 H, d, J=10.8); 4.77 (1 H, d, J=
11.0); 4.61 (1 H, d, J=12.3); 4.53 (1 H, d, J=12.3); 4.47
(1 H, d, J=10.8); 3.91–3.85 (2 H, m); 3.72 (1 H, dd, J=
10.7, 2.0); 3.68 (1 H, t, J=9.5); 3.67 (1 H, dd, J=10.9,
4.0); 3.61 (1 H, t, J=9.7); 3.58–3.49 (2 H, m); 3.40 (1 H,
t, J=9.3); 2.35–2.27 (1 H, m); 2.23–2.14 (2 H, m); 1.99
(1 H, dddd, J=14.0, 10.8, 8.9, 5.3); 1.88 (1 H, br. s); 1.85
(1 H, ddd, J=13.5, 12.0, 2.8); 1.58–1.50 (1 H, m). 13C-
NMR (100 MHz, CDCl3): 138.9; 138.2; 138.0; 137.6;
128.5; 128.4; 128.4; 128.1; 128.1; 128.1; 127.8; 127.8;
127.7; 116.7; 84.3; 79.4; 77.8; 77.7; 77.4; 75.4; 75.3; 74.7;
73.5; 71.3; 69.7; 69.0; 32.7; 29.5; 27.8. HR-EI-MS:
544.2845 (M+, C34H40O6
+; calc. 544.2825). EI-MS: 544
(11, M+), 543 (37), 181 (8), 91 (100). Anal. calc. for
C34H40O6: C 74.97, H 7.40; found: C 75.19, H 7.32.
Synthesis of Compound 29a from 29b. Solid Dess–
Martin periodinane (18 mg, 0.43 mmol) was added in
three portions over 1 h to a solution of alcohol 29b
(20 mg, 0.036 mmol) in dichloromethane (2 mL). The
mixture was poured into NaOH (3 M, 5 mL) and stirred
for 1 h. Dichloromethane (20 mL) was added and the
organic phase was separated and washed with brine
(10 mL). The organic phase was dried (MgSO4) and the
solvent removed in vacuo. The residue was purified by
flash column chromatography over silica gel (Et2O/
hexane 1 :1) to afford ketone (16.4 mg, 82%). Rf=0.72
(Et2O/hexane 1 :1). M.p.=61–62 °C. [α]D21 +1.93 (c=
1.05 in CHCl3). IR (CHCl3): 2869, 1726, 1641, 1454, 1363,
1097, 996, 909. 1H-NMR (500 MHz, CDCl3): 7.44–7.27
(13 H, m); 7.20–7.16 (2 H, m); 5.84 (1 H, dddd, J=17.0,
10.3, 6.7, 6.7); 5.10–5.02 (3 H, m); 4.92 (1 H, d, J 10.7);
4.85 (1 H, d, J=11.0); 4.63 (1 H, d, J=12.2); 4.56 (1 H, d,
J=12.2); 4.55 (1 H, d, J=11.0); 3.85 (1 H, dd, J=8.6,
3.6); 3.79–3.68 (4 H, m); 3.60–3.51 (3 H, m); 3.02 (1 H,
dd, J=16.1, 5.3); 2.59 (1 H, dd, J=16.1, 10.7); 2.34–2.17
(2 H, m); 2.09–2.01 (1 H, m); 1.73 (1 H, dddd, J=14.1,
8.9, 8.5, 5.3). 13C-NMR (100 MHz, CDCl3): 204.9; 138.6;
138.1; 137.9; 137.6; 128.4; 128.0; 128.0; 127.9; 127.8;
127.8; 115.6; 84.0; 82.0; 81.4; 79.2; 77.4; 75.3; 75.3; 74.3;
73.6; 68.9; 45.0; 29.4; 28.4. HR-EI-MS: 542.2680 (M+,
C34H38O6




1-yl)oxane (30). A solution of alcohol 20 (1.0 g,
2.1 mmol) in Et2O (10 mL) was added by cannula to a
suspension of KH (180 mg, 4.5 mmol) in Et2O (20 mL)
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at room temperature. The mixture was stirred for
10 min and then cooled to 0 °C. Freshly distilled
trichloroethene (320 mg, 2.40 mmol) in Et2O (2 mL)
was added dropwise to the solution. The mixture was
allowed to warm to room temperature and stirred for
1 h. The solution was then cooled to   78 °C and BuLi
(2.5 mL of a 2.5 M solution in hexanes, 6.3 mmol) was
added dropwise. The mixture was stirred at this
temperature for 30 min and then allowed to warm to
  40 °C and stirred for 45 min. The reaction was
quenched by the addition of methanol (5 mL), and the
resulting mixture was poured into a saturated solution
of NH4Cl (50 mL). The mixture was extracted with Et2O
(50 mL), and the organic phase was washed with brine
(50 mL) and then dried (MgSO4). The solvent was
removed in vacuo, and the residue was purified by
flash column chromatography over silica gel (Et2O/
hexane 1 :9 with 1% Et3N) to give the alkynyl ether 30
(960 mg, 91%) as a colourless oil. Rf=0.50 (Et2O/
hexane 1 :9). [α]D
20= +30.6 (c=0.960 in CHCl3). IR
(CHCl3): 3322, 2959, 2917, 2871, 2154, 1454, 1650,
1361, 1094, 999, 897. 1H-NMR (500 MHz, CDCl3): 7.51 (2
H, d, J=7.1); 7.45–7.34 (11 H, m); 7.31–7.27 (2 H, m);
5.08 (1 H, d, J=10.6); 4.97 (2 H, br. s); 4.92 (1 H, d, J=
10.8); 4.91 (1 H, d, J=10.6); 4.68 (1 H, d, J=12.2); 4.67
(1 H, d, J=10.8); 4.64 (1 H, d, J=12.2); 4.04 (1 H, t, J=
9.0); 3.92 (1 H, t, J=9.4); 3.81 (1 H, dd, J=11.0, 1.7);
3.77–3.70 (3 H, m); 3.50 (1 H, ddd, J=9.8, 4.4, 1.7); 2.71
(1 H, dd, J=14.6, 0.9); 2.41 (1 H, dd, J=14.6, 7.7); 1.91
(3 H, s); 1.74 (1 H, s). 13C-NMR (125 MHz, CDCl3): 141.8;
138.3; 138.2; 138.1; 128.5; 128.4; 128.3; 128.0; 127.9;
127.7; 127.6; 113.3; 88.9; 88.4; 83.2; 79.1; 78.2; 76.1;
75.5; 75.2; 73.5; 68.8; 39.4; 28.5; 23.4. HR-EI-MS:
512.2583 (M+, C33H36O5
+; calc. 512.2563). EI-MS: 512
(1, M+), 415 (2), 181 (6), 131 (8), 91 (100).
(2S,3R,4aS,6R,7R,8S,8aS)-7,8-Bis(benzyloxy)-6-
[(benzyloxy)methyl]-2-(but-3-en-1-yl)-3-methyl-
octahydropyrano[3,2-b]pyran-3-ol (32). A mixture of
copper bromide (213 mg, 1.50 mmol) and lithium
bromide (140 mg, 1.50 mmol) was dried at 60 °C for
4 h under high vacuum (<1 mbar) and then sus-
pended in THF (10 mL). The suspension was cooled to
  90 °C and the Grignard reagent 24 (3.0 mL of a
0.50 M solution in THF, 1.5 mmol) was added dropwise
over a period of 5 min. The resulting mixture was
stirred at   90 °C for 5 min. A solution of the alkynyl
ether 30 (500 mg, 1.00 mmol) in THF (10 mL) was
added dropwise at   90 °C and the mixture was
warmed to   78 °C then stirred for a further 30 min.
The reaction was quenched by the addition of a 10%
aqueous solution of NH4OH (50 mL) and the mixture
was extracted with Et2O (2×50 mL). The combined
organic extracts were dried (MgSO4) and the solvent
was removed in vacuo. The residue was purified by
flash column chromatography over silica gel
(hexane!Et2O/hexane 1 :20 with 1% Et3N) to afford
the enol ether 31 (530 mg, 84%) as a colourless oil.
Rf=0.53 (Et2O/hexane 1 :9). The unstable enol ether
was used immediately in the subsequent RCM reac-
tion.
A solution of alkene 31 (0.45 g, 0.67 mmol) in
toluene (30 mL) was added a solution of ruthenium
complex 14 (29 mg, 34 μmol) in benzene (40 mL) at
room temperature under an atmosphere of argon, and
the mixture was heated at reflux for 4 h. The solvent
was removed in vacuo and the residue was purified by
flash column chromatography over silica gel (Et2O/
hexane 1 :7 with 1% Et3N) to give a complex mixture
of products (323 mg) as colourless oil.
A solution of thexylborane (5.0 mL of a 0.50 M
solution in THF, 2.5 mmol) was added dropwise to the
mixture of enol ethers (0.32 g, 0.47 mmol) in THF
(5 mL) at   20 °C. The mixture was stirred at   20 °C for
30 min, then warmed to 0 °C. After a further 30 min,
the ice bath was removed, and the mixture was stirred
for 1 h. The reaction was quenched by the slow
addition of methanol (1 mL). After 5 min, pH 7 buffer
(5 mL) and NaBO3 (430 mg, 5 mmol) were added, and
the mixture was agitated vigorously for 3 h. AcOEt
(50 mL) was added and the solution was washed with
brine (2×25 mL). The aqueous washings were ex-
tracted with AcOEt (2×50 mL). The combined organic
extracts were dried (MgSO4) and the solvent was
removed in vacuo. The residue was dissolved in AcOEt
(100 mL) and filtered through a plug of silica. The
solvent was removed in vacuo and the residue was
dissolved in neat trifluoroacetic acid (2 mL) and stirred
for 2 min. The acid was neutralised by slow addition of
a saturated solution of K2CO3 and the aqueous mixture
was extracted with Et2O (3×50 mL). The combined
organic extracts were dried (MgSO4) and the solvent
was removed in vacuo. The residue was purified by
flash column chromatography over silica gel (Et2O/
hexane 1 :4!3 :6) to give the alcohol 32 (81 mg, 22%
over two steps) as a clear oil. Rf=0.32 (Et2O/hexane
1 :1). [α]D
24= +9.3 (c=0.85 in CHCl3). IR (CHCl3): 3610,
2926, 2856, 1640, 1073, 997, 943, 912. 1H-NMR
(500 MHz, CDCl3): 7.33–7.22 (13 H, m); 7.12–7.09 (2 H,
m); 5.81 (1 H, dddd, J=16.9, 10.2, 6.6, 6.6); 5.01 (1 H, d,
J=11.2); 5.02–4.97 (1 H, m); 4.95 (1 H, d, J=10.2); 4.83
(1 H, d, J=10.8); 4.74 (1 H, d, J=11.2); 4.55 (1 H, d, J=
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www.helv.wiley.com (11 of 15) e1900161 © 2019 The Authors. Helvetica Chimica Acta Published by Wiley-VHCA AG
12.2); 4.50 (1 H, d, J=12.2); 4.44 (1 H, d, J=10.8); 3.67
(1 H, dd, J=10.7, 1.4); 3.61 (1 H, t, J=8.4); 3.60 (1 H, dd,
J=10.7, 5.2); 3.52 (1 H, dd, J=9.8, 8.4); 3.46 (1 H, ddd,
J=9.8, 4.7, 1.5); 3.18–3.12 (2 H, m); 3.10 (1 H, dd, J=
9.6, 4.2); 2.38–2.29 (1 H, m); 2.20 (1 H, dd, J=11.3, 4.2);
2.17–2.08 (1 H, m); 1.79–1.71 (1 H, m); 1.62 (1 H, t, J=
11.3); 1.66–1.53 (1 H, m); 1.49–1.40 (1 H, m); 1.19 (3 H,
s). 13C-NMR (125 MHz, CDCl3): 138.8; 138.3; 138.2;
138.1; 128.4; 128.0; 128.0; 128.0; 127.8; 127.7; 127.7;
115.1; 84.2; 83.8; 83.3; 79.4; 77.7; 75.3; 75.1; 73.9; 73.5;
70.9; 69.2; 45.6; 30.9; 27.8; 21.7. HR-EI-MS: 558.2989
(M+, C34H42O6
+; calc. 558.2981). EI-MS: 558 (3, M+),




Copper cyanide (34 mg, 0.38 mmol) was dried at 60 °C
for 4 h under high vacuum (<1 mbar) and then
suspended in THF (5 mL). The suspension was cooled
to   78 °C and lithium dimethylphenylsilane (0.75 mL
of a 1.0 M solution in THF, 0.75 mmol) was added
dropwise and the resulting solution stirred at   78 °C
for 30 min. Allene (1.5 mL of a 2.0 M solution in THF,
3.0 mmol) was added and the mixture was warmed to
  30 °C for 30 min. The mixture was cooled to   78 °C
and the alkyne 22 (250 mg, 0.501 mmol) in THF
(10 mL) was added dropwise over 5 min at   78 °C. The
mixture was stirred for a further 10 min, and the
reaction was quenched by the addition of a 10%
aqueous solution of NH4OH (20 mL). The mixture was
extracted with Et2O (2×50 mL), and the combined
organic extracts were dried (MgSO4). The solvent was
removed in vacuo, and the residue was purified by
flash column chromatography over silica gel
(hexane!Et2O/hexane 1 :10 with 1% Et3N) to afford
enol ether 33 (242 mg, 73%) as a colourless oil. Rf 0.65
(Et2O/hexane 1 :9). [α]D
23= +2.5 (c=0.56 in CHCl3). IR
(CHCl3): 2232, 2922, 2155, 1095.
1H-NMR (500 MHz,
CDCl3): 7.50–7.48 (2 H, m); 7.35–7.22 (15 H, m); 7.17–
7.14 (2 H, m); 5.90 (1 H, dddd, J=17.1, 10.3, 6.9, 6.9);
5.46 (1 H, d, J=1.8); 5.10–5.03 (2 H, m); 4.81 (1 H, d,
J=10.9); 4.78 (1 H, d, J=10.7); 4.77 (1 H, br. s); 4.64 (1
H, d, J=10.7); 4.62 (1 H, d, J=11.2); 4.58 (1 H, br. s);
4.56 (1 H, d, J=11.2); 4.54 (1 H, d, J=10.9); 4.46 (1 H, d,
J=2.8); 4.02 (1 H, dd, J=9.1, 9.1); 3.73 (1 H, dd, J=
10.8, 1.2); 3.70 (1 H, t, J=9.1, 9.1); 3.67 (1 H, dd, J=
10.8, 4.2); 3.61 (1 H, dd, J=9.7, 9.1); 3.44 (1 H, ddd, J=
9.7, 4.2, 1.2); 3.38 (1 H, ddd, J=9.1, 8.6, 2.8); 2.46–2.39
(1 H, m); 2.19 (1 H, ddd, J=14.7, 8.6, 6.9); 1.97 (2 H, s);
0.28 (6 H, s). 13C-NMR (125 MHz, CDCl3): 159.7; 140.1;
139.1; 138.6; 138.4; 134.8; 134.1; 133.8; 133.7; 131.9;
129.1; 128.4; 128.3; 128.2; 128.0; 127.8; 127.7; 127.6;
117.2; 111.5; 87.7; 86.2; 79.7; 79.1; 79.0; 78.0; 75.2; 73.5;




nylsilane (34). A solution of the alkene 33 (202 mg,
0.299 mmol) in toluene (15 mL) was added to a
solution of ruthenium catalyst 14 (37 mg, 23 μmol) in
benzene (15 mL) at room temperature under an
atmosphere argon. The solution was heated at 80 °C
for 4 h. The solvent was removed in vacuo and the
crude product was purified by flash column chroma-
tography over silica gel (Et2O/hexane 1 :9 with 1%
Et3N) to give cyclic enol ether 34 (146 mg, 76%) as
colourless oil. Rf=0.70 (Et2O/hexane, 2 : 8). [α]D
23=
+14.2 (c=0.950 in CHCl3). IR (CHCl3): 2950, 2869,
1460, 1090. 1H-NMR (500 MHz, CDCl3): 7.48–7.45 (2 H,
m); 7.37–7.34 (2 H, m); 7.31–7.22 (14 H, m); 7.13–7.09
(2 H, m); 5.27 (1 H, d, J=0.9); 5.06 (1 H, d, J=11.1); 4.84
(1 H, d, J=10.7); 4.81 (1 H, d, J=11.1); 4.77 (1 H, dd, J=
5.3, 2.4); 4.69 (1 H, br. s); 4.57 (1 H, d, J=12.2); 4.52 (1
H, d, J =12.2); 4.48 (1 H, d, J=10.7); 3.75 (1 H, dd, J=
8.8, 8.8); 3.69 (1 H, dd, J=10.7, 1.5); 3.64 (1 H, dd, J=
10.7, 4.7); 3.59 (1 H, dd, J=9.5, 9.0); 3.50 (1 H, dd, J=
9.4, 9.1); 3.48–3.51 (1 H, m); 3.37 (1 H, ddd, J=9.6, 9.5,
6.4); 2.30 (1 H, ddd, J=17.2, 6.4, 5.3); 2.11 (1 H, ddd, J=
17.2, 9.6, 2.4); 1.91 (1 H, d, J=14.0); 1.86 (1 H, d, J=
14.0); 0.27 (6 H, s). 13C-NMR (125 MHz, CDCl3): 151.9;
138.9; 138.9; 138.8; 138.3; 138.0; 134.9; 133.7; 129.3;
129.1; 128.4; 128.1; 128.1; 128.0; 127.7; 110.1; 97.5;
84.4; 79.4; 78.9; 77.5; 75.3; 75.2; 73.6; 69.1; 27.9; 22.5;
  2.9;   3.0.
(2R,3R,4S,5S,6S)-3,4-Bis(benzyloxy)-2-[(benzyl-
oxy)methyl]-6-(but-3-en-1-yl)-5-(ethynyloxy)oxane
(36). A solution of alcohol 21 (1.5 g, 3.0 mmol) in Et2O
(10 mL) was added by cannula to a suspension of KH
(0.28 g, 7.0 mmol) in Et2O (15 mL) at room temper-
ature. The mixture was stirred for 10 min and then
cooled to 0 °C. A solution of freshly distilled trichloro-
ethene (0.48 g, 3.7 mmol) in Et2O (5 mL) was added
dropwise and the mixture was allowed to warm to
room temperature then stirred for 1 h. The mixture
was cooled to   78 °C and BuLi (4 mL of a 2.5 M
solution in hexanes, 10.0 mmol) was added dropwise.
The mixture was stirred at this temperature for 30 min
and then allowed to warm to   40 °C and stirred for
45 min. The reaction was quenched by the addition of
methanol (5 mL), and the resulting mixture was
poured into a saturated solution of NH4Cl (80 mL). The
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biphasic mixture was extracted with Et2O (2×100 mL)
and the organic phases were combined and washed
with brine (100 mL) then dried (MgSO4). The solvent
was removed in vacuo, and the residue was purified by
flash column chromatography over silica gel (Et2O/
hexane 1 :9 with 1% Et3N) with to give alkyne 36
(1.35 g, 86%) as a colourless oil. Rf=0.49 (Et2O/hexane
1 :9). [α]D
21= +32.3 (c=1.85 in CHCl3). IR (CHCl3):
3322, 2913, 2868, 2151, 1641, 1093, 996, 944, 912. 1H-
NMR (400 MHz, CDCl3): 7.31–7.13 (13 H, m); 7.08–7.04
(2 H, m); 5.76 (1 H, dddd, J=17.0, 10.2, 6.6, 6.6); 4.98 (1
H, dddd, J=17.0, 1.7, 1.7, 1.7); 4.91 (1 H, dddd, J=10.2,
1.7, 1.4, 1.4); 4.81 (1 H, d, J=10.8); 4.71 (1 H, d, J=
10.8); 4.64 (1 H, d, J=10.8); 4.52 (1 H, d, J=12.1); 4.40
(1 H, d, J=12.1); 4.38 (1 H, d, J=10.8); 4.26–4.20 (2 H,
m); 3.76 (1 H, dd, J=8.3, 8.3); 3.60 (1 H, dd, J=10.5,
3.8); 3.59–3.48 (3 H, m); 2.21–2.10 (1 H, m); 2.08–1.97
(1 H, m); 1.77–1.58 (2 H, m); 1.51 (1 H, s). 13C-NMR
(125 MHz, CDCl3): 138.0; 137.9; 137.4; 128.4; 128.4;
128.1; 127.9; 127.8; 127.7; 115.4; 89.7; 87.5; 80.4; 77.5;
75.2; 75.0; 73.5; 72.0; 71.4; 68.7; 29.0; 27.1; 24.1. HR-ESI-





Copper bromide (225 mg, 1.59 mmol) and lithium
bromide (138 mg, 1.59 mmol) were dried at 60 °C for
4 h under high vacuum (<1 mbar) and then sus-
pended in THF (15 mL). The suspension was cooled to
–100 °C and the Grignard reagent 24 (3.2 mL of 0.5 M
solution in THF, 1.6 mmol) was added dropwise over a
period of 5 min. The resulting mixture was stirred at
  90 °C for 5 min and the alkyne 36 (270 mg,
0.53 mmol) in THF (15 mL) was added dropwise over
5 min at   90 °C. The mixture was allowed to warm to
  78 °C, and the solution was stirred at this temper-
ature for a further 1 h. The reaction was quenched by
the addition of a 10% aqueous solution of NH4OH
(50 mL), and the resulting mixture was extracted with
Et2O (2×80 mL). The combined organic extracts were
dried (MgSO4), filtered and the solvent was removed in
vacuo. The residue was purified by flash column
chromatography over silica gel (hexane!Et2O/hexane
1 :20 with 1% Et3N) to afford enol ether 37 (252 mg,
68%) as a colourless oil. Rf 0.5 (Et2O/hexane 1 :4). IR
(liquid film): 2950, 2865, 1615, 1090. 1H-NMR (400 MHz,
CDCl3): 7.41–7.25 (2 H, m); 7.20–7.08 (15 H, m); 6.99–
6.94 (3 H, m); 5.64 (1 H, ddt, J=16.9, 10.2, 6.6); 5.54–
5.51 (1 H, m); 5.27–5.25 (1 H, m); 4.86 (1 H, dd, J=16.9,
1.8); 4.81 (1 H, dd, J=10.2, 1.8); 4.64 (1 H, d, J=10.8);
4.64 (1 H, d, J=10.8); 4.51 (1 H, d, J=11.2); 4.48 (1 H, d,
J=12.7); 4.34 (1 H, d, J=12.2); 4.29 (1 H, d, J=10.8);
4.18–4.05 (2 H, m); 3.89 (1 H, d, J=2.4); 3.75 (1 H, d,
J=2.4); 3.66 (1 H, t, J=8.5); 3.55 (1 H, dd, J=10.5, 4.0);
3.53–3.41 (3 H, m); 2.20–2.11 (2 H, m); 2.10–1.93 (3 H,
m); 1.92–1.79 (1 H, m); 1.61 (1 H, dddd, J=14.4, 11.1,
9.3, 5.1); 1.44–1.31 (1 H, m); 0.19 (6 H, s); 13C-NMR
(101 MHz, CDCl3): 161.1; 149.6; 138.8; 138.3; 138.1;
138.1; 138.0; 138.0; 134.0; 129.1; 128.5; 128.4; 128.4;
128.2; 128.0; 128.0; 128.0; 127.9; 127.8; 127.8; 127.7;
125.9; 115.1; 82.6; 81.6; 77.9; 75.3; 75.1; 73.6; 71.6; 71.1;
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